Insights into the arginine paradox: Evidence against the importance of subcellular location of arginase and eNOS

Shawn Elms, Feng Chen, Yusi Wang, Jin Qian, Bardia Askari, Yanfang Yu, Deepesh Pandey, Jennifer Iddings, Ruth B. Caldwell, David J.R. Fulton

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Reduced production of nitric oxide (NO) is one of the first indications of endothelial dysfunction and precedes overt cardiovascular disease. Increased expression of Arginase has been proposed as a mechanism to account for diminished NO production. Arginases consume L-arginine, the substrate for endothelial nitric oxide synthase (eNOS), and L-arginine depletion is thought to competitively reduce eNOS-derived NO. However, this simple relationship is complicated by the paradox that L-arginine concentrations in endothelial cells remain sufficiently high to support NO synthesis. One mechanism proposed to explain this is compartmentalization of intracellular L-arginine into distinct, poorly interchangeable pools. In the current study, we investigated this concept by targeting eNOS and Arginase to different intracellular locations within COS-7 cells and also BAEC. We found that supplemental L-arginine and L-citrulline dose-dependently increased NO production in a manner independent of the intracellular location of eNOS. Cytosolic arginase I and mitochondrial arginase II reduced eNOS activity equally regardless of where in the cell eNOS was expressed. Similarly, targeting arginase I to disparate regions of the cell did not differentially modify eNOS activity. Arginase-dependent suppression of eNOS activity was reversed by pharmacological inhibitors and absent in a catalytically inactive mutant. Arginase did not directly interact with eNOS, and the metabolic products of arginase or downstream enzymes did not contribute to eNOS inhibition. Cells expressing arginase had significantly lower levels of intracellular L-arginine and higher levels of ornithine. These results suggest that arginases inhibit eNOS activity by depletion of substrate and that the compartmentalization of L-arginine does not play a major role.

Original languageEnglish (US)
Pages (from-to)H651-H666
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume305
Issue number5
DOIs
StatePublished - Sep 1 2013

Fingerprint

Arginase
Nitric Oxide Synthase Type III
Arginine
Nitric Oxide
Citrulline
Ornithine
COS Cells
Cardiovascular Diseases
Endothelial Cells
Pharmacology

Keywords

  • Arginase
  • Endothelial nitric oxide synthase
  • L-arginine
  • Nitric oxide
  • Urea

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Insights into the arginine paradox : Evidence against the importance of subcellular location of arginase and eNOS. / Elms, Shawn; Chen, Feng; Wang, Yusi; Qian, Jin; Askari, Bardia; Yu, Yanfang; Pandey, Deepesh; Iddings, Jennifer; Caldwell, Ruth B.; Fulton, David J.R.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 305, No. 5, 01.09.2013, p. H651-H666.

Research output: Contribution to journalArticle

Elms, Shawn ; Chen, Feng ; Wang, Yusi ; Qian, Jin ; Askari, Bardia ; Yu, Yanfang ; Pandey, Deepesh ; Iddings, Jennifer ; Caldwell, Ruth B. ; Fulton, David J.R. / Insights into the arginine paradox : Evidence against the importance of subcellular location of arginase and eNOS. In: American Journal of Physiology - Heart and Circulatory Physiology. 2013 ; Vol. 305, No. 5. pp. H651-H666.
@article{50e0345cf1c546069c2494c375f8ab7c,
title = "Insights into the arginine paradox: Evidence against the importance of subcellular location of arginase and eNOS",
abstract = "Reduced production of nitric oxide (NO) is one of the first indications of endothelial dysfunction and precedes overt cardiovascular disease. Increased expression of Arginase has been proposed as a mechanism to account for diminished NO production. Arginases consume L-arginine, the substrate for endothelial nitric oxide synthase (eNOS), and L-arginine depletion is thought to competitively reduce eNOS-derived NO. However, this simple relationship is complicated by the paradox that L-arginine concentrations in endothelial cells remain sufficiently high to support NO synthesis. One mechanism proposed to explain this is compartmentalization of intracellular L-arginine into distinct, poorly interchangeable pools. In the current study, we investigated this concept by targeting eNOS and Arginase to different intracellular locations within COS-7 cells and also BAEC. We found that supplemental L-arginine and L-citrulline dose-dependently increased NO production in a manner independent of the intracellular location of eNOS. Cytosolic arginase I and mitochondrial arginase II reduced eNOS activity equally regardless of where in the cell eNOS was expressed. Similarly, targeting arginase I to disparate regions of the cell did not differentially modify eNOS activity. Arginase-dependent suppression of eNOS activity was reversed by pharmacological inhibitors and absent in a catalytically inactive mutant. Arginase did not directly interact with eNOS, and the metabolic products of arginase or downstream enzymes did not contribute to eNOS inhibition. Cells expressing arginase had significantly lower levels of intracellular L-arginine and higher levels of ornithine. These results suggest that arginases inhibit eNOS activity by depletion of substrate and that the compartmentalization of L-arginine does not play a major role.",
keywords = "Arginase, Endothelial nitric oxide synthase, L-arginine, Nitric oxide, Urea",
author = "Shawn Elms and Feng Chen and Yusi Wang and Jin Qian and Bardia Askari and Yanfang Yu and Deepesh Pandey and Jennifer Iddings and Caldwell, {Ruth B.} and Fulton, {David J.R.}",
year = "2013",
month = "9",
day = "1",
doi = "10.1152/ajpheart.00755.2012",
language = "English (US)",
volume = "305",
pages = "H651--H666",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Insights into the arginine paradox

T2 - Evidence against the importance of subcellular location of arginase and eNOS

AU - Elms, Shawn

AU - Chen, Feng

AU - Wang, Yusi

AU - Qian, Jin

AU - Askari, Bardia

AU - Yu, Yanfang

AU - Pandey, Deepesh

AU - Iddings, Jennifer

AU - Caldwell, Ruth B.

AU - Fulton, David J.R.

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Reduced production of nitric oxide (NO) is one of the first indications of endothelial dysfunction and precedes overt cardiovascular disease. Increased expression of Arginase has been proposed as a mechanism to account for diminished NO production. Arginases consume L-arginine, the substrate for endothelial nitric oxide synthase (eNOS), and L-arginine depletion is thought to competitively reduce eNOS-derived NO. However, this simple relationship is complicated by the paradox that L-arginine concentrations in endothelial cells remain sufficiently high to support NO synthesis. One mechanism proposed to explain this is compartmentalization of intracellular L-arginine into distinct, poorly interchangeable pools. In the current study, we investigated this concept by targeting eNOS and Arginase to different intracellular locations within COS-7 cells and also BAEC. We found that supplemental L-arginine and L-citrulline dose-dependently increased NO production in a manner independent of the intracellular location of eNOS. Cytosolic arginase I and mitochondrial arginase II reduced eNOS activity equally regardless of where in the cell eNOS was expressed. Similarly, targeting arginase I to disparate regions of the cell did not differentially modify eNOS activity. Arginase-dependent suppression of eNOS activity was reversed by pharmacological inhibitors and absent in a catalytically inactive mutant. Arginase did not directly interact with eNOS, and the metabolic products of arginase or downstream enzymes did not contribute to eNOS inhibition. Cells expressing arginase had significantly lower levels of intracellular L-arginine and higher levels of ornithine. These results suggest that arginases inhibit eNOS activity by depletion of substrate and that the compartmentalization of L-arginine does not play a major role.

AB - Reduced production of nitric oxide (NO) is one of the first indications of endothelial dysfunction and precedes overt cardiovascular disease. Increased expression of Arginase has been proposed as a mechanism to account for diminished NO production. Arginases consume L-arginine, the substrate for endothelial nitric oxide synthase (eNOS), and L-arginine depletion is thought to competitively reduce eNOS-derived NO. However, this simple relationship is complicated by the paradox that L-arginine concentrations in endothelial cells remain sufficiently high to support NO synthesis. One mechanism proposed to explain this is compartmentalization of intracellular L-arginine into distinct, poorly interchangeable pools. In the current study, we investigated this concept by targeting eNOS and Arginase to different intracellular locations within COS-7 cells and also BAEC. We found that supplemental L-arginine and L-citrulline dose-dependently increased NO production in a manner independent of the intracellular location of eNOS. Cytosolic arginase I and mitochondrial arginase II reduced eNOS activity equally regardless of where in the cell eNOS was expressed. Similarly, targeting arginase I to disparate regions of the cell did not differentially modify eNOS activity. Arginase-dependent suppression of eNOS activity was reversed by pharmacological inhibitors and absent in a catalytically inactive mutant. Arginase did not directly interact with eNOS, and the metabolic products of arginase or downstream enzymes did not contribute to eNOS inhibition. Cells expressing arginase had significantly lower levels of intracellular L-arginine and higher levels of ornithine. These results suggest that arginases inhibit eNOS activity by depletion of substrate and that the compartmentalization of L-arginine does not play a major role.

KW - Arginase

KW - Endothelial nitric oxide synthase

KW - L-arginine

KW - Nitric oxide

KW - Urea

UR - http://www.scopus.com/inward/record.url?scp=84883412740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883412740&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00755.2012

DO - 10.1152/ajpheart.00755.2012

M3 - Article

C2 - 23792682

AN - SCOPUS:84883412740

VL - 305

SP - H651-H666

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5

ER -